Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective
Name:
Publisher version
UMass Chan Affiliations
Department of DermatologyDocument Type
Accepted ManuscriptPublication Date
2020-05-13Keywords
COVID-19SARS-CoV-2
coronavirus
dermoscopy
en bloc excision
hemostasis
longitudinal melanonychia
melanocytic activation
nail biopsy
nail matrix nevusnail unit melanomaonychoscopypandemicsubungual melanomatelemedicineDermatologyHealth Services AdministrationInfectious DiseaseSkin and Connective Tissue DiseasesTelemedicineVirus Diseases
Metadata
Show full item recordAbstract
To the editor: 34 Longitudinal melanonychia (LM) is the presenting sign of nail unit melanoma (NUM) in 2/3 35 of cases and is therefore among the most important conditions managed by dermatologists. In 36 normal times, referral for LM would prompt an expedited appointment for clinical 37 examination and dermoscopy.1 However, due to SARS-CoV-2, dermatologists have been 38 asked to reconsider “urgent/emergency” conditions. The COVID-19 pandemic has propelled 39 physicians to unexpectedly adopt telemedicine without adequate guidance for managing LM 40 patients.Source
Lipner SR, Iorizzo M, Jellinek N, Piraccini BM, Scher RK. Considerations for Management of Longitudinal Melanonychia During the COVID-19 Pandemic: An International Perspective. J Am Acad Dermatol. 2020 May 13. doi: 10.1016/j.jaad.2020.05.028. Epub ahead of print. PMID: 32405124; PMCID: PMC7217794. Link to article on publisher's site
DOI
10.1016/j.jaad.2020.05.028Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27519PubMed ID
32405124Related Resources
Rights
© 2020 by the American Academy of Dermatology. This is a PDF file of an accepted manuscript that has been accepted for publication and posted with a 12-month embargo and CC BY-NC-ND license as allowed by the publisher's author rights policy at https://www.elsevier.com/about/policies/sharing.Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2020 by the American Academy of Dermatology. This is a PDF file of an accepted manuscript that has been accepted for publication and posted with a 12-month embargo and CC BY-NC-ND license as allowed by the publisher's author rights policy at https://www.elsevier.com/about/policies/sharing.